Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00152633

Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension

Status
Withdrawn
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Erlangen-Nürnberg Medical School · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Essential hypertension is commonly associated with impaired endothelial function. The retinal vasculature is morphologically and functionally related to the cerebral vessels because of the common origin from the internal carotid artery. A recent study in hypertensive patients demonstrated that endothelial function of the retinal vasculature is impaired in hypertensive patients and that it can be restored by treatment with an AT1-receptor antagonist. It is not clear whether this effect is due to blood pressure lowering or whether this is a blood pressure independent effect. The present randomized, double blind study with a cross over design addresses this issue by comparing the effects of losartan and metoprolol on retinal endothelial function in patients with essential hypertension.

Conditions

Interventions

TypeNameDescription
DRUGLosartan
DRUGMetoprolol
DRUGLosartanTreatment with Losartan

Timeline

Start date
2005-09-01
Primary completion
2006-01-01
Completion
2006-01-01
First posted
2005-09-09
Last updated
2012-07-06

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00152633. Inclusion in this directory is not an endorsement.